A/Prof Piers Blombery
Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology
259 Scholarly works
6 Projects
HIGHLIGHTS
2024
Research grants (ARC, NHMRC, MRFF)
ADAPT (Achieving Durable Remission via Adaptive Pro-Survival Targeting in Acute Myeloid Leukaemia)
2023
Journal article
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia
DOI: 10.1182/blood.20220160902022
Journal article
Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapy
DOI: 10.1182/blood.20220160402022
Journal article
Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistance
DOI: 10.1182/bloodadvances.20220083252022
Journal article
Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL
DOI: 10.1182/blood.20210127752022
Research grants (ARC, NHMRC, MRFF)
Understanding and Averting Blood Cancer Resistance to Therapy
2021
Research grants (ARC, NHMRC, MRFF)
INTERCEPT (Investigating Novel Therapy to Target Early Relapse and Clonal Evolution as Pre-Emptive Therapy in AML): A Multi-Arm, Precision-Based, Recursive, Platform Trial
RECENT SCHOLARLY WORKS
2026
Journal article
T-ALL: the origin story
DOI: 10.1182/blood.20250329442026
Journal article
MPL W515R hereditary thrombocytosis associated with a benign long-term clinical course
DOI: 10.1016/j.pathol.2025.12.0102026
Journal article
HAT-PCR is non-inferior to NGS when quantifying measurable residual disease for myeloma
DOI: 10.1111/bjh.704782026
Journal article
Activating somatic EPOR mutation in primary erythrocytosis
DOI: 10.1016/j.pathol.2026.04.0052026
Journal article
Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE study
DOI: 10.1002/hem3.703862026
Journal article
The landscape and evolution of clonal hematopoiesis in chronic lymphocytic leukemia
DOI: 10.1182/blood.20250299052026
Journal article
Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma
DOI: 10.1182/bloodadvances.20250166462026
Journal article
Refinement of the classification of DDX41 variants through analysis of aggregated clinical datasets
DOI: 10.1038/s41375-026-02886-6